|
Elena's Biotech Briefing
Distilled Bio uses AI to process and generate content for you. Verify important details using the linked sources.
AI-generated briefing: Zhimeng completed enrollment in its pivotal ALS drug trial, Opentrons raised $40 million for lab automation, and Life Extension screened 600,000 molecules.
The top 10 stories from Fri Oct 30, 2026 06:46 AM to Mon Nov 2, 2026 06:47 AM
Generated November 2, 2026 at 6:47 AM
|
|
|
#1 Anthropic's Nathan Frey on biopharma partners, M&A and pipeline Published 2026-10-30 Nathan Frey, who leads drug discovery research at Anthropic after its acquisition of Coefficient Bio, discussed biopharma partnerships, mergers and acquisitions, and the company’s pipeline. Covered by: endpoints.news |
#2 100 Million-Cell AI-Ready Dataset with Single-Cell and Proteomic Data Created by Parse and Nomic Published 2026-10-30 Parse Biosciences and Nomic Bio are partnering on Cascade, a dataset combining 100 million single-cell RNA profiles and over 11,000 proteomic profiles across more than 150,000 immune-cell perturbation conditions. Covered by: genengnews.com |
#3 Zhimeng Biopharma has completed the patients enrollment of its investigational drug, CB03-154, in the pivotal Phase 2/3 ALS clinical trial. Published 2026-10-31 Zhimeng Biopharma completed patient enrollment in the pivotal Phase 2/3 trial of its investigational ALS drug, CB03-154. Covered by: prnewswire.com |
#4 Life Extension and PIPA Search 600,000 Molecules in 13 Weeks and Identify New Bioactive Candidates Published 2026-10-30 Life Extension and PIPA used PIPA’s platform to screen 600,000 molecules in 13 weeks and identify new bioactive candidates. Covered by: prnewswire.com |
#5 Galien Forum Notebook: AI, Pricing, Protectionism And How Size Matters Published 2026-10-30 Pfizer CEO Albert Bourla discussed AI, drug pricing, protectionism and company scale at the 2026 Galien Forum. Covered by: insights.citeline.com |
#6 Opentrons Raises $40M in Series E to Expand Its Robotics, Software, Data Infrastructure Published 2026-10-30 Opentrons raised $40 million in a Series E led by Avego to expand its lab robotics, software, AI-driven experiment automation, and international reach. Covered by: genengnews.com |
#7 Post-Hoc Live: Is biotech’s future full of zero- and one- employee startups? Published 2026-10-30 Anthropic acquired Mithril Medicine, a biotech run by one employee with AI and contractors, prompting discussion about whether such lean startups signal biotech’s future. Covered by: endpoints.news, endpoints.news |
#8 Ophthalmology Has A Long History With AI, But Sees Modern Challenges Published 2026-10-30 AI in ophthalmology was valued at $209.23 million in 2024 and is projected to reach $1.36 billion by 2030. Covered by: insights.citeline.com |
#9 US Biopharma IPO Total Nears $9bn As Bambusa, Aspen Launch Offerings Published 2026-10-30 Bambusa and Aspen’s offerings bring the US biopharma IPO count to 29, with total proceeds nearing $9 billion. Covered by: insights.citeline.com |
#10 STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings Published 2026-10-30 Federal health officials are working to prevent regulatory conflicts as states test clinical AI, which may fall under state medical-practice rules or FDA oversight. Covered by: statnews.com |
